Hyeoung‐Joon Kim

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae et al. · Cancer Chemotherapy and Pharmacology · 2007 · 112 citations

Medicine, Oncology, Chemotherapy +13

Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

Tae‐Hyung Kim, Joon Ho Moon, Jae-Sook Ahn et al. · Blood · 2018 · 110 citations · Full text

Medicine, Hematology, Oncology +15

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

Deok‐Hwan Yang, Jung‐Joon Min, Ho‐Chun Song et al. · European Journal of Cancer · 2011 · 88 citations

Medicine, Oncology, Chemotherapy +8

Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes

Yun‐Gyoo Lee, Inho Kim, Sung‐Soo Yoon et al. · British Journal of Haematology · 2013 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Ga‐Young Song, Sung‐Hoon Jung, Seok Jin Kim et al. · BMC Cancer · 2020 · 72 citations · Full text

Veterinary Medicine, Immunology, Oncology +15